- Fund Type: Open-End Fund
- Objective: Govt/Agency-Long Term
- Asset Class: Debt
- Geographic Focus: Mexico
Finaccess - Latin2 SA de CV SIIDPF
+ Add to WatchlistAXESPATB:MM
2.01 MXN 0.000.00%As of 09:29:30 ET on 05/24/2013.
Snapshot for Finaccess - Latin2 SA de CV SIIDPF (AXESPATB)
| Year To Date: | -3.54% | 3-Month: | -2.39% | 3-Year: | -0.36% | 52-Week Range: | 1.96 - 2.23 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +0.51% | 1-Year: | -8.37% | 5-Year: | +4.66% | Beta vs FCOMPAN: | 0.98 |
Fund Profile & Information for AXESPATB
Latin2 SA de CV SIID para Personas Fisicas is an open-end fund incorporated in Mexico. The Fund's objective is capital appreciation. The Fund invests in short-term government fixed-income securities.
| Inception Date: | 09-07-2000 | Telephone: | 5255-5081-1000 |
|---|---|---|---|
| Managers: | CARLOS RODRIGUEZ GIACINTI | ||
| Web Site: | www.finaccess.com.mx | ||
Fundamentals for AXESPATB
| NAV | (on 2013-05-24) 2.01 |
|---|---|
| Assets (M) | (on 2013-03-27) 114.14 |
| Fund Leveraged | N |
| Minimum Investment | 40,000.00 |
| Minimum Subsequent Investment | - |
Dividends for AXESPATB
No dividends reported
Fees & Expenses for AXESPATB
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.68 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for AXESPATB
Filing Date: 03/27/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| MEX 11 ⅜ 09/15/16 | 2,000 | 33,545,770 | 31.631% |
| PENOMX Float 08/12/15 | 10,000 | 12,374,778 | 11.669% |
| MBPA Float 07/05/18 | 100,000 | 10,027,657 | 9.455% |
| MBPA Float 06/11/15 | 50,000 | 5,064,521 | 4.775% |
| MBPA Float 06/29/17 | 50,000 | 5,031,099 | 4.744% |
| CEDEVI 4.4 04/22/30 | 2,750 | 2,083,891 | 1.965% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page